Table of Contents
ISRN Endocrinology
Volume 2011 (2011), Article ID 810251, 5 pages
http://dx.doi.org/10.5402/2011/810251
Research Article

Prevalence of Subclinical Hypothyroidism among Patients with Acute Myocardial Infarction

1Cardiology Clinic, Bağcılar Education and Research Hospital, Bagcilar, 34200 Istanbul, Turkey
2Internal Medicine Clinic, John F Kennedy Hospital, 34100 Istanbul, Turkey
3General Surgery Clinic, Bağcılar Education and Research Hospital, 34200 Istanbul, Turkey

Received 27 April 2011; Accepted 8 June 2011

Academic Editor: C. Bizzarri

Copyright © 2011 Okuyan Ertugrul et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Cooper, “Subclinical hypothyroidism,” The New England Journal of Medicine, vol. 345, no. 4, pp. 260–265, 2001. View at Google Scholar
  2. J. G. Hollowell, N. W. Staehling, W. D. Flanders et al., “Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III),” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 489–499, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Karmisholt, S. Andersen, and P. Laurberg, “Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism,” Thyroid, vol. 18, no. 3, pp. 303–308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. G. J. Kahaly, “Cardiovascular and atherogenic aspects of subclinical hypothyroidism,” Thyroid, vol. 10, no. 8, pp. 665–679, 2000. View at Google Scholar · View at Scopus
  5. Z. Efstathiadou, S. Bitsis, H. J. Milionis et al., “Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?” European Journal of Endocrinology, vol. 145, no. 6, pp. 705–710, 2001. View at Google Scholar · View at Scopus
  6. P. A. Bastenie, L. Vanhaelst, and P. Neve, “Coronary-artery disease in hypothyroidism,” The Lancet, vol. 2, no. 7528, pp. 1221–1222, 1967. View at Google Scholar · View at Scopus
  7. W. M. G. Tunbridge, D. C. Evered, and R. Hall, “Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure,” Clinical Endocrinology, vol. 7, no. 6, pp. 495–508, 1977. View at Google Scholar
  8. J. L. Johnson and D. S. Duick, “Diabetes and thyroid disease: a likely combination,” Diabetes Spectrum, vol. 15, no. 3, pp. 140–142, 2002. View at Google Scholar
  9. S. Miura, M. Iitaka, S. Suzuki et al., “Decrease in serum levels of thyroid hormone in patients with coronary heart disease,” Endocrine Journal, vol. 43, no. 6, pp. 657–663, 1996. View at Google Scholar · View at Scopus
  10. A. E. Hak, H. A. P. Pols, T. J. Visser, H. A. Drexhage, A. Hofman, and J. C. M. Witteman, “Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the rotterdam study,” Annals of Internal Medicine, vol. 132, no. 4, pp. 270–278, 2000. View at Google Scholar · View at Scopus
  11. J. W. Chu and L. M. Crapo, “The treatment of subclinical hypothyroidism is seldom necessary,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 10, pp. 4591–4599, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. M. T. McDermott and E. C. Ridgway, “Subclinical hypothyroidism is mild thyroid failure and should be treated,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 10, pp. 4585–4590, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. A. R. Cappola, L. P. Fried, A. M. Arnold et al., “Thyroid status, cardiovascular risk, and mortality in older adults,” Journal of the American Medical Association, vol. 295, no. 9, pp. 1033–1041, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Helfand, “Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. preventive services task force,” Annals of Internal Medicine, vol. 140, no. 2, pp. 128–I58, 2004. View at Google Scholar · View at Scopus
  15. M. I. Surks, E. Ortiz, G. H. Daniels et al., “Subclinical thyroid disease: scientific review and guidelines for diagnosis and management,” Journal of the American Medical Association, vol. 291, no. 2, pp. 228–238, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. P. Vanderpump, W. M. Tunbridge, J. M. French et al., “The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community,” Thyroid, vol. 6, no. 3, pp. 155–160, 1996. View at Google Scholar · View at Scopus
  17. N. Rodondi, D. Aujesky, E. Vittinghoff, J. Cornuz, and D. C. Bauer, “Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis,” American Journal of Medicine, vol. 119, no. 7, pp. 541–551, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Ochs, R. Auer, D. C. Bauer et al., “Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality,” Annals of Internal Medicine, vol. 148, no. 11, pp. 832–845, 2008. View at Google Scholar · View at Scopus
  19. S. Singh, J. Duggal, J. Molnar, F. Maldonado, C. P. Barsano, and R. Arora, “Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis,” International Journal of Cardiology, vol. 125, no. 1, pp. 41–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Haentjens, A. Van Meerhaeghe, K. Poppe, and B. Velkeniers, “Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies,” European Journal of Endocrinology, vol. 159, no. 3, pp. 329–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Razvi, A. Shakoor, M. Vanderpump, J. U. Weaver, and S. H. Pearce, “The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 8, pp. 2998–3007, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Biondi and D. S. Cooper, “The clinical significance of subclinical thyroid dysfunction,” Endocrine Reviews, vol. 29, no. 1, pp. 76–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Canaris, N. R. Manowitz, G. Mayor, and E. C. Ridgway, “The colorado thyroid disease prevalence study,” Archives of Internal Medicine, vol. 160, no. 4, pp. 526–534, 2000. View at Google Scholar · View at Scopus
  24. M. D. Danese, P. W. Ladenson, C. L. Meinert, and N. R. Powe, “Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 9, pp. 2993–3001, 2000. View at Google Scholar · View at Scopus
  25. S. Razvi, L. Ingoe, G. Keeka, C. Oates, C. McMillan, and J. U. Weaver, “The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 5, pp. 1715–1723, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Monzani, N. Caraccio, M. Kozàkowà et al., “Effect of levothyroxine replacement on lipid profile and ontima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 5, pp. 2099–2106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Caraccio, E. Ferrannini, and F. Monzani, “Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 4, pp. 1533–1538, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Meier, J. J. Staub, C. B. Roth et al., “TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (basel thyroid study),” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 10, pp. 4860–4866, 2001. View at Publisher · View at Google Scholar
  29. A. Iqbal, R. Jorde, and Y. Figenschau, “Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the tromsø study,” Journal of Internal Medicine, vol. 260, no. 1, pp. 53–61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Gussekloo, E. van Exel, A. J. de Craen, A. E. Meinders, M. Frölich, and R. G. Westendorp, “Thyroid status, disability and cognitive function, and survival in old age,” Journal of the American Medical Association, vol. 292, no. 21, pp. 2591–2599, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. D. Toft, “Clinical practice. Subclinical hyperthyroidism,” The New England Journal of Medicine, vol. 345, no. 7, pp. 512–516, 2001. View at Google Scholar · View at Scopus
  32. B. Akinci, A. Comlekci, S. Yener et al., “The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism,” Hormones (Athens), vol. 6, no. 4, pp. 327–333, 2007. View at Google Scholar · View at Scopus
  33. B. Biondi, “Cardiovascular effects of mild hypothyroidism,” Thyroid, vol. 17, no. 7, pp. 625–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Christ-Crain, C. Meier, M. Guglielmetti et al., “Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? a cross-sectional and a double-blind, placebo-controlled trial,” Atherosclerosis, vol. 166, no. 2, pp. 379–386, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Masunaga, A. Nagasaka, A. Nakai et al., “Alteration of platelet aggregation in patients with thyroid disorders,” Metabolism, vol. 46, no. 10, pp. 1128–1131, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Chadarevian, E. Bruckert, L. Leenhardt, P. Giral, A. Ankri, and G. Turpin, “Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 2, pp. 732–737, 2001. View at Publisher · View at Google Scholar · View at Scopus